An innovative one-time treatment that harnesses a patient’s own immune system to fight advanced melanoma could help people ...

The Royal Horticultural Society has named a coral-pink rose "Catherine’s Rose" in honor of the Princess of Wales to raise ...

Almost one in five patients with advanced melanoma survived for five years after receiving lifileucel, a trial has found.

Approximately 70% of breast cancers are HR-positive/HER2 negative. While activating ESR1 mutations are rare at the time of ...

A NEW triple threat drug combination could hold aggressive breast cancer at bay for an extra year, a trial found. Adding the ...

Data presented at ASCO show that swapping in the oral drug camizestrant for an older therapy helped sustain the benefit of ...

The internationally renowned cancer centre is working on the project – billed as the UK's first large-scale, AI-powered ...

Together with its principal academic partner, The Institute of Cancer Research (ICR), The Royal Marsden is designated as the ...

Six London NHS Trusts are set to benefit from new “cutting-edge” technology which will help doctors to target tumours with ...